5 big analyst AI moves: Apple lifted to Buy, AI chip bets reassessed
Oracle NASDAQ:ORCL Executive Vice President, Chief Accounting Officer Maria Smith, sold 10,000 shares of Oracle Corp common stock for a total of $2.8 million, according to a Form 4 filing with the Securities and Exchange Commission. The sale comes as Oracle, now valued at nearly $800 billion, trades above its InvestingPro Fair Value with a P/E ratio of 65.
The sales occurred in two separate transactions. On October 21, 2025, Smith sold 5,000 shares at a price of $280.00 per share. Then, on October 23, 2025, she sold another 5,000 shares at a weighted average price of $280.6245, with individual sales prices ranging from $280.59 to $280.71. The stock has shown remarkable strength, delivering a 69% return over the past year.
Following these transactions, Smith directly owns 47,083 shares of Oracle stock. InvestingPro subscribers can access 18 additional key insights and a comprehensive Pro Research Report about Oracle’s valuation and future prospects.
In other recent news, Oracle has been in the spotlight with several significant developments. UBS has reiterated its Buy rating for Oracle, setting a price target of $380, following observations from the company’s AI World event where customer interest appeared robust. Meanwhile, JPMorgan has downgraded Oracle’s credit rating to Neutral, highlighting concerns over the substantial capital needed for its AI expansion and the lack of clarity in its financing strategy. On the innovation front, Oracle has added AI features to its Public Safety Suite, enhancing capabilities for law enforcement and first responders with AI-powered analytics and voice command functionalities.
Additionally, Oracle Health and Life Sciences has partnered with Baylor College of Medicine to advance research on alcohol-related liver disease, aiming to leverage Oracle’s AI data platform for significant patient cohort expansion. In another strategic move, Sunnybrook Health Sciences Centre in Toronto has chosen Oracle Health to implement a new AI-powered electronic health record system to streamline healthcare operations. These developments underscore Oracle’s ongoing efforts to expand its AI capabilities and partnerships across various sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.